Details for New Drug Application (NDA): 076525
✉ Email this page to a colleague
NDA 076525 describes TERIL, which is a drug marketed by Taro and is included in two NDAs. It is available from three suppliers. Additional details are available on the TERIL profile page.
The generic ingredient in TERIL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
The generic ingredient in TERIL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
Summary for 076525
| Tradename: | TERIL |
| Applicant: | Taro |
| Ingredient: | carbamazepine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 076525
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Sep 26, 2003 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
